Avidity Biosciences, Inc. (RNA) SEC EDGAR filings (10-Q, 8-K), newest first; latest 10-Q filed 2026-08-13. Every filing links to the canonical SEC document. First-party data.
| Filed | Form | Title |
|---|---|---|
| 2026-08-13 | 10-Q | 10-Q filed 2026-08-13 by Atrium Therapeutics, Inc. |
| 2026-08-13 | 8-K | 8-K filed 2026-08-13 by Atrium Therapeutics, Inc. |
| 2026-07-14 | 8-K | 8-K filed 2026-07-14 by Atrium Therapeutics, Inc. |
| 2026-05-14 | 10-Q | 10-Q filed 2026-05-14 by Atrium Therapeutics, Inc. |
| 2026-05-14 | 8-K | 8-K filed 2026-05-14 by Atrium Therapeutics, Inc. |
| 2026-02-27 | 8-K | 8-K filed 2026-02-27 by Atrium Therapeutics, Inc. |
| 2026-02-26 | 8-K | 8-K filed 2026-02-26 by Atrium Therapeutics, Inc. |
RNA overview · RNA earnings · RNA financials · RNA KPIs · RNA investor relations · RNA ownership · RNA peers
Data sourced from U.S. SEC EDGAR. Not personalized investment advice.